Matthew M. Cooney

1 ta ish

Case Comprehensive Cancer Center

1. Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer

   Pedro C. Barata, Matthew M. Cooney, Prateek Mendiratta +3

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.003160